Killin is a p53-regulated nuclear inhibitor of DNA synthesis

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• The tumor suppressor p53 protein is known to induce cell growth arrest and apoptosis.
• p21 is a major mediator of G(1) arrest but its role in preventing apoptosis is unclear.
• The precise mechanisms linking p53 activation to apoptosis and cell cycle control require further elucidation.

Purpose of the Study:

• To identify novel p53 target genes involved in apoptosis.
• To investigate the function of a newly discovered gene, Killin, in p53-mediated cellular responses.
• To understand the role of Killin in S phase checkpoint control and elimination of precancerous cells.

Main Methods:

• Gene discovery and characterization of a novel p53 target gene, Killin.
• Genetic and biochemical analyses to determine Killin's DNA-binding properties and functional domains.
• In vitro inhibition assays for eukaryotic DNA synthesis.
• In vivo studies to assess S phase arrest and apoptosis induction.

Main Results:

• Discovery of Killin, a p53 target gene encoding a 20-kDa nuclear protein, located on human chromosome 10.
• Killin is both necessary and sufficient for p53-induced apoptosis.
• Killin is a high-affinity DNA-binding protein that inhibits DNA synthesis in vitro.
• Killin triggers S phase arrest in vivo prior to apoptosis.
• The DNA-binding domain responsible for DNA synthesis inhibition is located within the N-terminal 42 amino acids of Killin.

Conclusions:

• Killin acts as a crucial mediator of p53-induced apoptosis.
• Killin functions as a DNA synthesis inhibitor, inducing S phase arrest.
• Killin represents a missing link between p53 activation and S phase checkpoint control.
• Killin plays a role in eliminating precancerous cells that escape G(1) arrest.